Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Exelixis FDA extends NDA review for zanzalintinib
The FDA extended review of Exelixis's NDA for zanzalintinib plus atezolizumab by three months, setting a new PDUFA date of March 3, 2027.